A study conducted by Ahsan et al. demonstrated the NLRP3 inhibitory activity of tocotrienol in type 2 diabetes mouse models by two approaches: it impairs the NLRP3 priming by inhibiting NFϏβ and blocks NLRP3 activation. The gene discussed is NLRP3; the disease is type 2 diabetes mellitus.